Methylation Density, Expression Levels, and Leukemia Type for Each Sample Where Both Methylation and RNA Could Be Analyzed
| Sample . | p15 Expression . | % Methylation . | Classification . |
|---|---|---|---|
| KG1a | — | 97.7% | AML |
| L56 | — | 50.4% | AML |
| L63 | — | 37.9% | AML |
| L105 | +/++ | 7.8% | B-ALL |
| L41 | + | 6.0% | AML |
| L117 | +++ | 2.1% | B-ALL |
| Normal | ++++ | 1.8%-3.3% | Mononuclear cells |
| HL60 | +++/++++ | 1.5% | AML |
| L161 | + | 0.5% | B-ALL |
| L3 | ++++ | 0.4% | AML |
| L5* | ++ | 65.6% | AML |
| L224* | + | 85.5% | T-ALL |
| L157* | +/++ | 91.4% | T-ALL |
| Sample . | p15 Expression . | % Methylation . | Classification . |
|---|---|---|---|
| KG1a | — | 97.7% | AML |
| L56 | — | 50.4% | AML |
| L63 | — | 37.9% | AML |
| L105 | +/++ | 7.8% | B-ALL |
| L41 | + | 6.0% | AML |
| L117 | +++ | 2.1% | B-ALL |
| Normal | ++++ | 1.8%-3.3% | Mononuclear cells |
| HL60 | +++/++++ | 1.5% | AML |
| L161 | + | 0.5% | B-ALL |
| L3 | ++++ | 0.4% | AML |
| L5* | ++ | 65.6% | AML |
| L224* | + | 85.5% | T-ALL |
| L157* | +/++ | 91.4% | T-ALL |
Denotes densely methylated leukemia samples with at least 1 fully unmethylated allele present.